| known also as: |
Cripto-1 Growth Factor, Cripto-3, TDGF1, TDGF2, Teratocarcinoma-derived growth factor 1), Anti-Cripto (CRGF |
| known also as: |
Cripto-1 Growth Factor, Cripto-3, TDGF1, TDGF2, Teratocarcinoma-derived growth factor 1), Cripto (CRGF |
| known also as: |
Cripto-1 Growth Factor, Cripto-3, TDGF1, TDGF2, TeRattus norvegicusocarcinoma-derived growth factor 1), Cripto (CRGF |
| known also as: |
Cripto |
| known also as: |
Cripto-1 Growth Factor, Cripto-3, TDGF1, TDGF2, Teratocarcinoma-derived growth factor 1), Anti -Cripto (CRGF |
| Other names: |
N/A, N/A, cryptic protein, one eyed pinhead, one-eyed pinhead, teratocarcinoma-derived growth factor 1, cryptic protein |
| Other gene names: |
N/A, N/A, cb85, cripto, tdgf1, wu:fe01d04, zgc:109829, oep |
| Category: |
Antibodies |
| Clonality: |
Polyclonal |
| Clone: |
Polyclonal antibody |
| Host organism: |
Source: Mouse, Host: Rabbit |
| Species reactivity: |
Mouse, Human |
| Specificity and cross-reactivity: |
Species Crossreactivity: This antibody reacts with human cripto protein, The immunogen used for this antibody production has 78% homology with human protein and 100% with mouse protein, There is no significant homology with any other species, This antibody is specific for cripto |
| Purification method: |
Affinity Purified by peptide immunoaffinity chromatography |
| Form/Appearance: |
Tris-glycine and 150mM NaCl |
| Storage and shipping: |
Aliquots are stable for at least 12 months productone should be stored at -20 degrees Celsius, For long-term storage and to avoid repeated freezing and thawing, For maximum recovery of product, Further dilutions can be made in assay buffer, aliquot For optimal long term storage, centrifuge the original vial after thawing and prior to removing the cap, productone should be kept at -20 degrees Celsius, Store at 4 degrees Celsius for short term storage |
| Tested for:: |
Western Blot (WB) |
| Description: |
Complex subunit associated factors are involved in hybridoma growth, Eosinohils, NFKB 105 subunit for example is a polypetide gene enhancer of genes in B cells, eritroid proliferation and derived from promotor binding stimulating subunits on the DNA binding complex, transcription related growth factors and stimulating factors or repressing nuclear factors are complex subunits of proteins involved in cell differentiation, Aplha |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of productone unchanged |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals_1 they should be stored frozen at - 24° |
| Gene target: |
Cripto-1 Growth Factor, Cripto-3, TDGF1, TDGF2, Teratocarcinoma-derived growth factor 1), Cripto (CRGF |
| Short name: |
Cripto-1 Growth Factor, Cripto-3, TDGF1, TDGF2, Teratocarcinoma-derived growth factor 1) Antibody, Cripto (CRGF |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
Cripto-1 Growth Factor, Cripto-3, TDGF2, Teratocarcinoma-derived growth factor 1) (Antibody to), teratocarcinoma-derived growth factor 1, Cripto (CRGF |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
CR and CRGF and CRIPTO, TDGF1 and IDBG-409017 and ENSG00000241186 and 6997, Tdgf1 and IDBG-202568 and ENSMUSG00000032494 and 21667, embryo and biological process this GO :0009790 and embryo development and biological process this GO :0009948 and anterior/posterior axis specification and biological process this GO :0009966 and regulation of signal transduction and biological process this GO :0009986 and cell surface and cellular component this GO :0010595 and positive regulation of endothelial cell migration and biological process this GO :0016324 and apical plasma membrane and cellular component this GO :0018105 and peptidyl-serine phosphorylation and biological process this GO :0019897 and extrinsic component of plasma membrane and cellular component this GO :0030154 and cell differentiation and biological process this GO :0030334 and regulation of cell migration and biological process this GO :0030335 and positive regulation of cell migration and biological process this GO :0030509 and BMP signaling pathway and biological process this GO :0030512 and negative regulation of transforming growth factor beta receptor signaling pathway and biological process this GO :0030879 and mammary gland development and biological process this GO :0031225 and anchored component of membrane and cellular component this GO :0035729 and cellular response to hepatocyte growth factor stimulus and biological process this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0044344 and cellular response to fibroblast growth factor stimulus and biological process this GO :0045121 and membrane raft and cellular component this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0048146 and positive regulation of fibroblast proliferation and biological process this GO :0048471 and perinuclear region of cytoplasm and cellular component this GO :0050731 and positive regulation of peptidyl-tyrosine phosphorylation and biological process this GO :0055007 and cardiac muscle cell differentiation and biological process this GO :0060070 and canonical Wnt signaling pathway and biological process this GO :0071346 and cellular response to interferon-gamma and biological process this GO :0071354 and cellular response to interleukin-6 and biological process this GO :0071356 and cellular response to tumor necrosis factor and biological process this GO :0071364 and cellular response to epidermal growth factor stimulus and biological process, growth factor activity, nuclei, this GO :0000187 and activation of MAPK activity and biological process this GO :0001570 and vasculogenesis and biological process this GO :0001701 and in utero embryonic development and biological process this GO :0001763 and morphogenesis of a branching structure and biological process this GO :0001954 and positive regulation of cell-matrix adhesion and biological process this GO :0002042 and cell migration involved in sprouting angiogenesis and biological process this GO :0005102 and receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005615 and extracellular space and cellular component this GO :0005634 and nucleus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005794 and this GO lgi apparatus and cellular component this GO :0007369 and gastrulation and biological process this GO :0007507 and heart development and biological process this GO :0008083 and growth factor activity and molecular function this GO :0008284 and positive regulation of cell proliferation and biological process this GO :0008595 and anterior/posterior axis specification, this GO :0005102 : receptor binding, this GO :0005102 : receptor binding and also this GO :0005515 : protein binding and also this GO :0008083 : growth factor activity, this GO :0005515 : protein binding, this GO :0008083 : growth factor activity, teratocarcinoma-derived growth factor 1 |
| Identity: |
11702 |
| Gene: |
TDGF1P2 |
More about : TDGF1P2 |
| Long gene name: |
teratocarcinoma-derived growth factor 1 pseudogene 2 |
| Synonyms gene: |
TDGF2 |
| Synonyms gene name: |
pseudogene , teratocarcinoma-derived growth factor 2 |
| Synonyms: |
CR-2 CRIPTO-2 |
| Locus: |
2q36, 3 |
| Discovery year: |
1999-09-28 |
| GenBank acession: |
Y09998 |
| Entrez gene record: |
22816 |
| Pubmed identfication: |
10393436 |
| RefSeq identity: |
NG_001244 |
| Havana BLAST/BLAT: |
OTTHUMG00000153585 |